Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the...

|About: Amarin Corporation PLC (AMRN)|By:, SA News Editor

Amarin (AMRN) +9% following a report that Teva (TEVA +0.7%) is leading the race to acquire the Irish biotech, which has a market cap of $1.6B, with AstraZeneca (AZN +0.4%) also in the hunt. Teva recently said it wasn't intending to make any major acquisitions, while it's also due to unveil a long-term overhaul in December.